Search results
Results from the WOW.Com Content Network
An antihemorrhagic (British English: antihaemorrhagic) agent is a substance that promotes hemostasis (a process which stops bleeding). [1] It may also be known as a hemostatic (also spelled haemostatic) agent. [2] Antihemorrhagic agents used in medicine have various mechanisms of action:
Ferric subsulfate solution is a styptic or hemostatic agent used after superficial skin biopsies. [1] Ferric subsulfate solution is also known as basic ferric sulfate solution or Monsel's solution. It has a recognised formula published in United States Pharmacopeia 29.
Surgicel is a hemostatic agent (blood-clot-inducing material) made of an oxidized cellulose polymer (polyanhydroglucuronic acid), manufactured by the Ethicon subsidiary of Johnson & Johnson. It was introduced into clinical practice in 1947.
Tranexamic acid is used for a short period before and after the surgery to prevent major blood loss and decrease the need for blood transfusions. [36] Tranexamic acid is used in dentistry in the form of a 5% mouth rinse after extractions or surgery in patients with prolonged bleeding time; e.g., from acquired or inherited disorders. [37]
Physical agents (gelatin sponge) – Gelatin sponges have been indicated as great hemostatic devices. Once applied to a bleeding area, a gelatin sponge quickly stops or reduces the amount of bleeding present. These physical agents are mostly used in surgical settings as well as after surgery treatments.
A hemostat (also called a hemostatic clamp; arterial forceps; and pean, after Jules-Émile Péan) is a tool used to control bleeding during surgery. [1] Similar in design to both pliers and scissors , it is used to clamp exposed blood vessels shut.
Dental anesthesia (or dental anaesthesia) is the application of anesthesia to dentistry. It includes local anesthetics , sedation , and general anesthesia. Local anesthetic agents in dentistry
Etamsylate is a haemostatic agent; also promotes angioprotective and proaggregant action. It stimulates thrombopoiesis and their release from bone marrow. Haemostatic action is due to activation of thromboplastin formation on damaged sites of small blood vessels and decrease of PgI2 (Prostacyclin) synthesis; it also facilitates platelet aggregation and adhesion, that at last induce decrease ...